Entheogens

DGAP-News: Cannovum AG starts European cannabis expansion with founding of Cannovum Iberia LDA

Retrieved on: 
Monday, September 6, 2021
Cannabis, Psychoactive drugs, Cannabis smoking, Entheogens, Legality of cannabis, Branches of biology

Cannovum AG (stock exchanges Dsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A2LQU21) has started its European cannabis expansion with its subsidiary, Cannovum Health eG.

Key Points: 
  • Cannovum AG (stock exchanges Dsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A2LQU21) has started its European cannabis expansion with its subsidiary, Cannovum Health eG.
  • The first step for this was founding Cannovum Iberia LDA, a joint venture between Cannovum and Portuguese entrepreneurs from the cannabis industry.
  • Cannovum Iberia will initially distribute cannabis pharmaceuticals to pharmacies in Portugal.
  • "We have reached the first milestone and successfully completed the founding process of Cannovum Iberia LDA.

Global Medical Cannabis Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, September 6, 2021
Alternative Medicine, Health, Medicinal plants, Health sciences, Psychoactive drugs, Branches of biology, Herbalism, Entheogens, Euphoriants, Cannabis smoking, Cannabis, Medical cannabis, Effects of cannabis, Medical cannabis research

Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family.

Key Points: 
  • Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family.
  • Owing to its therapeutic benefits, cannabis has been approved for medical use in numerous countries, with varying degrees of legal restrictions.
  • Clinical trials, research and development (R&D) activities and commercialization of cannabis-based indications are further expected to catalyze the growth of the market.
  • As a result, increasing disposable incomes are projected to create a positive impact on the demand for medical cannabis.

BioHarvest Sciences Inc. Announces a CAD 4 Million Private Placement to Accelerate Its Cannabis Development Program and Production Capacity in Israel

Retrieved on: 
Wednesday, August 4, 2021
Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Plants, Cannabis, Cannabis smoking, Rosids, VIVO Cannabis

The funds will enhance the Company's cash position to:

Key Points: 
  • The funds will enhance the Company's cash position to:
    Accelerate the Company's Cannabis development program.
  • Provide for the required system upgrades for the conversion of the existing 2 Tons/year VINIA facility into a Cannabis production facility to be operational in H1/2022.
  • Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.
  • Further, by adapting this technology to the Cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.'s objective is to become a leading supplier of Cannabis for both medicinal and legal recreational purposes.

SLANG Worldwide Returns to California Market through Strategic Partnership with Natura

Retrieved on: 
Wednesday, August 4, 2021
Cannabis, Cannabis smoking, Entheogens, Herbalism, Medical specialties, Clinical medicine, Medicine

Best-selling brand District Edibles is the first of many SLANG-branded products to be launched in California through this partnership

Key Points: 
  • Products will be manufactured exclusively by Natura Life + Science ("Natura"), a vertically integrated cannabis manufacturing company and available throughout the Golden State.
  • Through a previously announced strategic partnership, Natura has been granted an exclusive license to produce and distribute the SLANG product suite in California.
  • With this partnership, we have a dream team that will enable SLANG brands to thrive in California.
  • The Natura team is ecstatic to bring such a tasty and high-quality product to the California market."

From Red Gold to Olympic Gold: Seedo Corp. Seeks Solutions for Athletes and More

Retrieved on: 
Wednesday, August 4, 2021
Articles, Food and drink, Psychoactive drugs, Saffron, Entheogens, Euphoriants, Medicinal plants, Cannabis smoking, Nutraceutical, Seedo, Cannabis, Saffron trade

Similar to the approach of the indoor cannabis industry, Seedo hopes to be able to enhance the medicinal properties of this unique herb for use in pharmaceutical and nutraceutical applications.

Key Points: 
  • Similar to the approach of the indoor cannabis industry, Seedo hopes to be able to enhance the medicinal properties of this unique herb for use in pharmaceutical and nutraceutical applications.
  • With mental health entering the cultural conversation, Seedo Corp. hopes saffron will be seen as part of a new nature-based approach to mental health.
  • "Seedo Corp is committed to developing breakthroughs rooted in nature that are effective and safe for athletes and everyday consumers alike."
  • Seedo Corp hopes to expand the billion dollar saffron market by producing a reliable, consistent and large-scale supply of the spice.

The CanCoin Announces Scott de Mercado, Co-Founder of Cannabis Delivery Sciences to its Advisory Board

Retrieved on: 
Wednesday, August 4, 2021
Articles, Cannabis, Cannabis smoking, Entheogens, Euphoriants, Blockchain, Monetization

STOCKHOLM, Aug. 04, 2021 (GLOBE NEWSWIRE) -- (via Blockchain Wire) The CanCoin , a cannabis token designed to solve market friction and monetization in the European cannabis market, today announced Scott Mercado, co-founder of Cannabis Delivery Services, a subsidiary of Klaria Pharma Holding AB, to its advisory board.

Key Points: 
  • STOCKHOLM, Aug. 04, 2021 (GLOBE NEWSWIRE) -- (via Blockchain Wire) The CanCoin , a cannabis token designed to solve market friction and monetization in the European cannabis market, today announced Scott Mercado, co-founder of Cannabis Delivery Services, a subsidiary of Klaria Pharma Holding AB, to its advisory board.
  • His entrepreneurial focus includes tech, media and pharma, providing a perfect combination of value add to The CanCoins project.
  • The CanCoin is a cannabis token designed to address friction and monetization within the growing legal European cannabis market.
  • The CanCoin streamlines payments and processing, inventory management, patient monitoring, medical cannabis cards and tracking from seed to shelf.

Simplifya Appoints One of Country’s Top Cannabis Banking and Financial Services Experts as General Counsel and Chief Banking Officer

Retrieved on: 
Wednesday, August 4, 2021
Financial regulation, Cannabis, Cannabis smoking, Entheogens, Articles, Regulatory compliance, Money laundering, Bank, Economy, Crime

DENVER, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Simplifya (Simplifya or the Company), the leading regulatory and operational compliance software platform serving the cannabis industry, announced the appointment of one of the countrys top cannabis banking, financial services and compliance experts, Katrina Skinner , as the Companys General Counsel and Chief Banking Officer, reporting directly to Simplifya CEO and Co-Founder Marion Mariathasan .

Key Points: 
  • DENVER, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Simplifya (Simplifya or the Company), the leading regulatory and operational compliance software platform serving the cannabis industry, announced the appointment of one of the countrys top cannabis banking, financial services and compliance experts, Katrina Skinner , as the Companys General Counsel and Chief Banking Officer, reporting directly to Simplifya CEO and Co-Founder Marion Mariathasan .
  • She will also oversee the Companys entrance into the multi-million dollar banking, financial and payment-related services sector.
  • Despite the majority of states legalizing cannabis, the financial services industry has been reluctant to bank in the industry due to the risks associated with Anti-Money Laundering and Bank Secrecy Act regulations, said Simplifya General Counsel and Chief Banking Officer Katrina Skinner.
  • Prior to joining Burns & Levinson, Katrina served as president and general counsel of Safe Harbor Services, a leader in banking services for legal cannabis-related businesses.

New poll shows a strong base of Canadians overwhelmingly support controlled legal access to psilocybin-assisted therapy; Canadian Psychedelic Association responds with Memorandum of Regulatory Approval (MORA)

Retrieved on: 
Wednesday, August 4, 2021
Psychoactive drugs, Entheogens, Mycotoxins, Organophosphates, Psilocybin, Psychedelic drug, Branches of biology

With public support at an all-time high, the CPA will now focus on introducing evidence-informed regulations to officials at Health Canada.

Key Points: 
  • With public support at an all-time high, the CPA will now focus on introducing evidence-informed regulations to officials at Health Canada.
  • Dr. Kryskow has witnessed firsthand what legal access to psychedelic medicine can do for Canadians in need of new treatment options.
  • Cory Firth, the Executive Director of the Canadian Psychedelic Association is confident the proposed amendments will continue our collaborative effort with Health Canada.
  • 82% of Canadians polled support or somewhat support approval for allowing the use of psilocybin-assisted therapy.

Creo successfully completes commercial fermentation run

Retrieved on: 
Wednesday, August 4, 2021
Branches of biology, Academic disciplines, Articles, Roy Lipski, Entheogens, Euphoriants, Metabolism, Cannabinoid, Cannabis, PTC Creo, Creo, Fermentation

San Diego, CA August 4, 2021 Creo , an ingredient technology company with a proprietary platform for producing natural cannabinoids without the cannabis plant, announced today the successful completion of its first commercial fermentation run at 28,000 L scale with performance that exceeded the Companys expectations.

Key Points: 
  • San Diego, CA August 4, 2021 Creo , an ingredient technology company with a proprietary platform for producing natural cannabinoids without the cannabis plant, announced today the successful completion of its first commercial fermentation run at 28,000 L scale with performance that exceeded the Companys expectations.
  • The commercial fermentation produced CBGA which is being processed into finished CBGA and CBG for client sampling and sales.
  • Were pleased with the performance of this commercial fermentation run at 28,000 L, which follows our successful demonstration campaign in January said Creos CEO, Roy Lipski.
  • Creo is an ingredients technology company that produces high quality cannabinoids using the natural process of fermentation.

Item 9 Labs to Host its Third Quarter Fiscal Year 2021 Earnings Call on August 17 at 11:00 a.m. ET

Retrieved on: 
Wednesday, August 4, 2021
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Medical specialties, Clinical medicine, Medicine

Item 9 Labs CEOAndrew Bowdenand CFOBobby Mikkelsenwill host the conference call.

Key Points: 
  • Item 9 Labs CEOAndrew Bowdenand CFOBobby Mikkelsenwill host the conference call.
  • A telephonic replay of the conference call will also be available until Tuesday, August 31, 2021 via the following call-in numbers:
    About Item 9 Labs Corp.
  • The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories.
  • Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.